Compliance of Thyroid Fine Needle Aspiration Biopsy and Trucut Biopsy Results With TIRADS Score and Surgical Pathology

Compliance of Thyroid Fine Needle Aspiration Biopsy and Trucut Biopsy Results With Thyroid Imaging Reporting and Data System Score and Surgical Pathology

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04488640

Acronym

TIRADS

Enrollment

Registered

2020-07-28

Start date

2017-01-01

Completion date

2020-05-01

Last updated

2020-07-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid Nodule

Keywords

TI-RADS score, Thyroid fine needle aspiration biopsy, Thyroid core needle biopsy, Surgical pathology

Brief summary

The investigators retrospectively reviewed the medical records of 760 patients with thyroid nodule biopsy and 88 patients who had thyroid surgery. The investigators evaluated patients' thyroid ultrasonography reports and determined Thyroid Imaging Reporting and Data System scores (TIRADS score: 1-Benign, 2- very low malignant) risk, 3-low risk, 4-medium risk, 5 -malignant high risk). The investigators evaluated patients 'existing thyroid fine needle aspiration biopsy (FNAB) reports and recorded the patients' cytology results (benign, malignant). Documents of 88 patients who were included in the study and who underwent thyroidectomy were reviewed.Pathology reports of these patients were evaluated and surgical pathology was determined as benign in 58 patients and malignant in 30 patients. Then, a statistical study was performed between the cor needle biopsy (CNB) results of these participants and the surgical pathology and TI-RADS scores.

Interventions

PROCEDUREThyroid biopsy with ultrasound

Patients with thyroid nodules who underwent ultrasound-guided core needle biopsy with a 20 gauge core needle biopsy apparatus were included in the study.

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

24 Years to 85 Years

Healthy volunteers

Inclusion criteria

* Having a thyroid nodule * Being both a thyroid needle and a core biopsy

Exclusion criteria

* Child patients * Pregnant patients * Patients without a thyroid needle biopsy

Design outcomes

Primary

Measure	Time frame	Description
Evaluation of the distribution of patients according to thyroid biopsy results.	4-year results were included.	Thyroid biopsy results (benign, malignant) will be compared with % of patients with these results. It will be analyzed statistically.
Examination of TIRADS score distribution according to thyroid biopsy results.	4-year results were included.	Thyroid biopsy results (benign, malignant) will be compared with the percentage of patients who fit the TIRADS score distribution (1-5). It will be analyzed statistically.
Evaluation of the compliance of TI-RADS scores with surgical pathology reports.	4-year results were included.	Surgical pathology results (benign, malignant) and TI-RADS scores (1 to 5) will be compared with% of patients matching the distribution (1-5). It will be analyzed statistically.
Evaluation of the distribution of thyroid biopsy results and surgical pathology results.	4-year results were included.	The % of patients who match the distribution of thyroid biopsy results (benign, malignant) and surgical pathology results (benign, malignant) will be compared. It will be analyzed statistically.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026